Design, Synthesis and Biological Evaluation of Novel Pyrimido[4,5-d]pyrimidine CDK2 Inhibitors as Anti-Tumor Agents
Abstract
Share and Cite
EL-MOGHAZY, S.M.; IBRAHIM, D.A.; ABDELGAWAD, N.M.; FARAG, N.A.H.; EL-KHOULY, A.S. Design, Synthesis and Biological Evaluation of Novel Pyrimido[4,5-d]pyrimidine CDK2 Inhibitors as Anti-Tumor Agents. Sci. Pharm. 2011, 79, 429-448. https://doi.org/10.3797/scipharm.1103-16
EL-MOGHAZY SM, IBRAHIM DA, ABDELGAWAD NM, FARAG NAH, EL-KHOULY AS. Design, Synthesis and Biological Evaluation of Novel Pyrimido[4,5-d]pyrimidine CDK2 Inhibitors as Anti-Tumor Agents. Scientia Pharmaceutica. 2011; 79(3):429-448. https://doi.org/10.3797/scipharm.1103-16
Chicago/Turabian StyleEL-MOGHAZY, Samir M., Diaa A. IBRAHIM, Nagwa M. ABDELGAWAD, Nahla A. H. FARAG, and Ahmad S. EL-KHOULY. 2011. "Design, Synthesis and Biological Evaluation of Novel Pyrimido[4,5-d]pyrimidine CDK2 Inhibitors as Anti-Tumor Agents" Scientia Pharmaceutica 79, no. 3: 429-448. https://doi.org/10.3797/scipharm.1103-16